Increase in IkappaB kinase alpha expression suppresses the tumor progression and improves the prognosis for nasopharyngeal carcinoma

Molecular Carcinogenesis

Volumn 54, Issue 2, 2015, Pages 156-165

  Deng, Ling ^a   Li, Yan ^a   Ai, Ping ^a   Xie, Yuxin ^a   Zhu, Hong ^a   Chen, Nianyong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

IkappaB kinase alpha; Nasopharyngeal carcinoma; Prognostic marker; Tumor malignant behaviors; Tumor suppressor

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; I KAPPA B KINASE ALPHA; I KAPPA B KINASE;

ADULT; ANGIOGENESIS; ARTICLE; CANCER TISSUE; CARCINOMA CELL LINE; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR INVASION; WESTERN BLOTTING; AGED; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LYMPHATIC METASTASIS; METABOLISM; METHYLATION; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B KINASE; LYMPHATIC METASTASIS; MALE; METHYLATION; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; SURVIVAL ANALYSIS;

EID: 84920573691     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22087     Document Type: Article

References (23)

1. Marinari B, Moretti F, Botti E, et al. The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway. Proc Natl Acad Sci USA 2008; 105:17091-17096.
2. Maeda G, Chiba T, Kawashiri S, Satoh T, Imai K. Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression. Clin Cancer Res 2007; 13:5041-5047.
3. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 2003; 423:655-659.
4. Takeda K, Takeuchi O, Tsujimura T, et al. Limb and skin abnormalities in mice lacking IKKalpha. Science 1999; 284:313-316.
5. Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999; 284:316-320.
6. Moreno-Maldonado R, Ramirez A, Navarro M, et al. IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas. Cell Cycle 2008; 7:2021-2029.
7. Liu B, Park E, Zhu F, et al. A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci USA 2006; 103:17202-17207.
8. Zhu F, Xia X, Liu B, Shen J, Hu Y, Person M. IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Mol Cell 2007; 27:214-227.
9. Park E, Zhu F, Liu B, et al. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res 2007; 67:9158-9168.
10. Xiao Z, Jiang Q, Willette-Brown J, et al. The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 2013; 23:527-540.
11. Lai SZ, Li WF, Chen L, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 2011; 80:661-668.
12. Song LB, Yan J, Jian SW, et al. Molecular mechanisms of tumorgenesis and metastasis in nasopharyngeal carcinoma cell sublines. Ai Zheng 2002; 21:158-162.
13. Gu L, Zhu N, Findley HW, Woods WG, Zhou M. Identification and characterization of the IKKalpha promoter: Positive and negative regulation by ETS-1 and p53, respectively. J Biol Chem 2004; 279:52141-52149.
14. Xia X, Park E, Fischer S, Hu Y. Mouse genetic models reveal surprising functions of IkB kinase alpha in skin development and skin carcinogenesis. Cancers 2013; 5:170-183.
15. Chua DT, Nicholls JM, Sham JS. Au GK. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59:11-20.
16. Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 2001; 8:11-31.
17. Tezil T, Bodur C, Kutuk O, Basaga H. IKK-beta mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death. Cell Signal 2012; 24:1361-1368.
18. Huang WC, Ju TK, Hung MC, Chen CC. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 2007; 26:75-87.
19. Bakkar N, Wang J, Ladner KJ, et al. IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 2008; 180:787-802.
20. Shembade N, Pujari R, Harhaj NS, Abbott DW, Harhaj EW. The kinase IKKalpha inhibits activation of the transcription factor NF-kappaB by phosphorylating the regulatory molecule TAX1BP1. Nat Immunol 2011; 12:834-843.
21. DeBusk LM, Massion PP, Lin PC. IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis. Cancer Res 2008; 68:10223-10228.
22. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441:431-436.
23. Valentine R, Dawson CW, Hu C, et al. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol Cancer 2010; 9:1.